Education
About Us
Working with TipRanks
Follow Us
Korro Bio (KRRO)
NASDAQ:KRRO
Total Valuation
Korro Bio has a market cap or net worth of $107.24M. The enterprise value is $135.24M.
Market Cap$107.24M
Enterprise Value$135.24M
Share Statistics
Korro Bio has 9,390,492 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,390,492
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Korro Bio’s return on equity (ROE) is -0.52 and return on invested capital (ROIC) is -43.31%.
Return on Equity (ROE)-0.52
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-43.31%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee20.28K
Profits Per Employee-746.26K
Employee Count112
Asset Turnover0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Korro Bio is -4.06. Korro Bio’s PEG ratio is -0.08.
PE Ratio-4.06
PS Ratio0.00
PB Ratio0.87
Price to Fair Value2.12
Price to FCF-1.87
Price to Operating Cash Flow-2.31
PEG Ratio-0.08
Income Statement
In the last 12 months, Korro Bio had revenue of 2.27M and earned -83.58M in profits. Earnings per share was -9.37.
Revenue2.27M
Gross Profit-1.29M
Operating Income-91.91M
Pretax Income-83.44M
Net Income-83.58M
EBITDA-88.34M
Earnings Per Share (EPS)-9.37
Cash Flow
In the last 12 months, operating cash flow was -60.07M and capital expenditures -17.90M, giving a free cash flow of -77.98M billion.
Operating Cash Flow-60.07M
Free Cash Flow-77.98M
Free Cash Flow per Share-8.30
Dividends & Yields
Korro Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.04
52-Week Price Change-77.38%
50-Day Moving Average15.91
200-Day Moving Average35.51
Relative Strength Index (RSI)34.03
Average Volume (3m)97.56K
Important Dates
Korro Bio upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend Date―
Financial Position
Korro Bio as a current ratio of 8.79, with Debt / Equity ratio of 27.91%
Current Ratio8.79
Quick Ratio8.79
Debt to Market Cap<0.01
Net Debt to EBITDA0.12
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Korro Bio has paid 141.00K in taxes.
Income Tax141.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Korro Bio EV to EBITDA ratio is -3.72, with an EV/FCF ratio of -4.22.
EV to Sales144.75
EV to EBITDA-3.72
EV to Free Cash Flow-4.22
EV to Operating Cash Flow-5.47
Balance Sheet
Korro Bio has $126.09M in cash and marketable securities with $44.77M in debt, giving a net cash position of -$81.33M billion.
Cash & Marketable Securities$126.09M
Total Debt$44.77M
Net Cash-$81.33M
Net Cash Per Share-$8.66
Tangible Book Value Per Share$17.98
Margins
Gross margin is 100.00%, with operating margin of -4047.12%, and net profit margin of -3680.36%.
Gross Margin100.00%
Operating Margin-4047.12%
Pretax Margin-3674.15%
Net Profit Margin-3680.36%
EBITDA Margin-3890.14%
EBIT Margin-4047.12%
Analyst Forecast
The average price target for Korro Bio is $92.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$92.33
Price Target Upside708.49% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast―
EPS Growth Forecast85.19%